Kazia Therapeutics (KZIA) Return on Capital Employed (2009 - 2011)

Kazia Therapeutics has reported Return on Capital Employed for 3 years, with the latest figure at 173.59% in Q4 2011.

• For the quarter ending Q4 2011, Return on Capital Employed rose 5048.0% year-over-year to 173.59%; the trailing twelve-month figure through Dec 2011 stood at 173.59% (up 5048.0% YoY), and the FY2025 full-year result was 27061.88%, down 3060797.0% from the prior year.
• Return on Capital Employed for Q4 2011 stood at 173.59%, up from 224.07% in the prior quarter.
• The five-year high for Return on Capital Employed was 139.57% in Q4 2009, with the low at 224.07% in Q4 2010.
• Historically, Return on Capital Employed has averaged 179.08% across 3 years, with a median of 173.59% in 2011.
• Annual changes were most pronounced in 2010 — Return on Capital Employed tumbled 8450 bps — and 2011, when it jumped 5048 bps.
• Kazia Therapeutics' Return on Capital Employed stood at 139.57% in 2009, then plunged by 61 bps to 224.07% in 2010, then rose by 23 bps to 173.59% in 2011.
• The last three Return on Capital Employed figures came in at 173.59% (Q4 2011), 224.07% (Q4 2010), and 139.57% (Q4 2009), per Business Quant data.